Related Experiment Video
Updated: Mar 12, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
[Unexpected Complications in the Withdrawal Treatment of the Research Chemical AH-7921]
A Bernius1, V Blaas2, D Rentsch2
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsmedizin Rostock.
Abstract:
We describe the case of a young male patient who had consumed the morphine-like substance AH-7921 which is available via the internet. He was initially admitted to hospital because of obstipation and presented within a day of inpatient treatment for the first time with a generalized tonic-clonic epileptic seizure with subsequent urinary retention. Within a few hours, the patient then also developed bradycardia, while at the same time describing symptoms of physical opioid withdrawal which gradually deteriorated within the following hours. We initiated a treatment with buprenorphine which resulted in a considerable reduction of withdrawal symptoms, so the patient could be discharged from hospital.
Related Concept Videos
Desensitization and Tachyphylaxis
Drug Abuse and Addiction: Pharmacological Phenomena
Toxidromes: Clinical Features
Drug Dependence
Drug Toxicity: Overview
Drug toxicity: Idiosyncratic Reactions

